TrialNeurology2024

Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.

Mitzi J Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.